Showing 2,021 - 2,040 results of 130,036 for search '(( i d decrease ) OR ( 5 ((step decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.97s Refine Results
  1. 2021
  2. 2022
  3. 2023

    Structure of YOLOv5s-SBC. by Zhongjian Xie (4633099)

    Published 2024
    “…Compared to the original model, P-YOLOv5s-GRNF decreased parameters by 18%, decreased model size to 11.9MB, decreased FLOPs to 14.5G, and increased FPS by 4.3. …”
  4. 2024
  5. 2025

    <i>cd9b</i> MO caused a decrease in neuromasts deposited at 52 hpf. by Katherine S. Marsay (11772718)

    Published 2021
    “…B-G: Representative images of WISH of <i>claudin b</i> at 52 hpf of (b) uninjected embryos, (c) embryos with 0.5 μM Mismatch, (d) 0.1 μM <i>cd9b</i> MO1, (e) 0.1 μM <i>cd9b</i> i2e3 MO1, (f) 0.2 μM <i>cd9b</i> MO1, (g) 0.2 μM <i>cd9b</i> i2e3 MO. …”
  6. 2026

    MeHg Exposure Makes O-2A/OPCs More Oxidized, Suppresses BrdU Incorporation, and Decreases Cell Division in Clonal Assays by Zaibo Li (273729)

    Published 2013
    “…In cultures exposed to MeHg, there was a decrease in the representation of large clones and a proportionate increase in the number of small clones and clones containing oligodendrocytes. …”
  7. 2027
  8. 2028

    Combination metabolic therapy decreases VM-M3 cell viability <i>in vitro</i>. by A. M. Poff (752552)

    Published 2015
    “…<b>(A-B)</b> βHB, LG, and LG+βHB+HBOT treatment decreased viability compared to control and HBOT treated cells. …”
  9. 2029

    Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>. by A. M. Poff (752552)

    Published 2015
    “…Cell density was measured with trypan blue hemocytometry to produce a growth curve over 96 hours. <b>(A)</b> Proliferation of VM-M3 cells was inhibited with decreasing glucose concentration and the addition of HBOT. …”
  10. 2030
  11. 2031
  12. 2032
  13. 2033
  14. 2034

    A summary of the included study characteristics. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  15. 2035
  16. 2036

    Loss of Lsd1 in long bone mesenchymal cells disrupts growth plate organization but not collagen maturation. by Petri Rummukainen (4247122)

    Published 2022
    “…<p>(A) Growth plates of Lsd1 knockout mice have decreased organization and thicker hypertrophic zone (right) compared to control (left) (n = 4–5 per group). …”
  17. 2037
  18. 2038
  19. 2039
  20. 2040